Phylloceuticals Leadership Selected for Intensive Capital Readiness Bootcamp

Welcome Jane Hollingsworth, Phylloceuticals newest board member

Phylloceuticals produces first plant-based PD-1 inhibitor

Phylloceuticals produces first batch of mAb PD-1 inhibitor after 12 weeks of operations

US Company hopes to transform access to advanced biologics

Welcome Nick Casale, Phylloceuticals first board member

Phylloceuticals Achieves Breakthrough: Production of Their First Biologic

CEO is interviewed by Perry Rearick, host of Trailblazers

CEO delivers successful pitch to Seattle Angel Conference

Plant-based pharmaceuticals company launches pilot facility in Rapid City